Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rank in Stocks #1815
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Share Price
$334.75
Last synced: 2024-05-30
Market Cap
$12.46B
Change (1 day)
-0.02%
Change (1 year)
0.00%
Country
US
Trade ShockWave Medical, Inc. (SWAV)

Category

P/B ratio for ShockWave Medical, Inc. (SWAV)
P/B ratio as of August 2026 TTM: 18.38
According to ShockWave Medical, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 18.38. At the end of 2022 the company had a P/B ratio of 14.44.
P/B ratio history for ShockWave Medical, Inc. from 2017 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 18.38 75.67%
2023 10.46 -27.54%
2022 14.44 -44.22%
2021 25.88 70.18%
2020 15.21 179.07%
2019 5.45 -79.73%
2018 26.88 -475.89%
2017 -7.15 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.7944 -79.35%
US
5.423 -70.49%
US
2.0146 -89.04%
IE
3.072 -83.28%
US
- -
DE